• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gen Virol . Latent gammaherpesvirus infection enhances type I IFN response and reduces virus spread in an influenza A virus co-infection model

tetano

Editor, Senior Moderator
J Gen Virol


. 2024 Feb;105(2).
doi: 10.1099/jgv.0.001962. Latent gammaherpesvirus infection enhances type I IFN response and reduces virus spread in an influenza A virus co-infection model

Gareth Hardisty[SUP] 1 2 [/SUP], Marlynne Q Nicol[SUP] 1 [/SUP], Darren J Shaw[SUP] 1 [/SUP], Ian D Bennet[SUP] 1 [/SUP], Karen Bryson[SUP] 1 [/SUP], Yvonne Ligertwood[SUP] 1 [/SUP], Jurgen Schwarze[SUP] 2 [/SUP], Philippa M Beard[SUP] 1 3 [/SUP], John Hopkins[SUP] 1 [/SUP], Bernadette M Dutia[SUP] 1 [/SUP]



Affiliations
Abstract

Infections with persistent or latent viruses alter host immune homeostasis and have potential to affect the outcome of concomitant acute viral infections such as influenza A virus (IAV). Gammaherpesviruses establish life-long infections and require an on-going immune response to control reactivation. We have used a murine model of co-infection to investigate the response to IAV infection in mice latently infected with the gammaherpesvirus MHV-68. Over the course of infection, latently infected BALB/c mice showed less weight loss, clinical signs, pulmonary cellular infiltration and expression of inflammatory mediators than naïve mice infected with IAV and had significantly more activated CD8[SUP]+[/SUP] T cells in the lungs. Four days after IAV infection, virus spread in the lungs of latently infected animals was significantly lower than in naïve animals. By 7 days after IAV infection latently infected lungs express elevated levels of cytokines and chemokines indicating they are primed to respond to the secondary infection. Investigation at an early time point showed that 24 h after IAV infection co-infected animals had higher expression of IFNβ and Ddx58 (RIG-I) and a range of ISGs than mice infected with IAV alone suggesting that the type I IFN response plays a role in the protective effect. This effect was mouse strain dependent and did not occur in 129/Sv/Ev mice. These results offer insight into innate immune mechanisms that could be utilized to protect against IAV infection and highlight on-going and persistent viral infections as a significant factor impacting the severity of acute respiratory infections.

Keywords: ISGs; co-infections; heterologous protection; innate immune response.

 
Back
Top Bottom